Clarifying a Complex Cancer Breakthrough, Delivering Corporate Success
Each new cancer innovation can be “make-or-break.” A Ritz Communications client had the capability of providing a complete photodynamic delivery system to physicians challenged by difficult-to-treat, hard-to-reach head and neck cancers. It was an exciting advance in cancer care for a biopharmaceutical company specializing in novel therapies to treat orphan diseases.
In explaining this complex product and corporate story, Ritz:
- Leveraged key product milestones during critical phases of both the product’s and the company’s life cycle, including media relations support from the clinical trial stage through FDA approval
- Built relationships with clinical trial sites to assess needs and developed website and collateral material to ensure their success
- Developed media strategies with investigators and PR departments at major research institutions such as the University of Pennsylvania, Roswell Park Cancer Institute and the Medical College of Wisconsin
- Supported the company as it navigated an FDA Special Protocol Assessment, FDA approval and product launch
- Secured national and targeted trade media coverage ranging from Reutersto BioOptics to increase awareness of the technology and its potential applications
- Strategically positioned the technology and the company during milestone PR opportunities to set the stage for successful acquisition by a larger company – the client’s ultimate goal
“Ritz Communications strong background in product communications and ability to dive deep into the science helped us shape messaging and develop stories for the outlets and platforms that mattered most to us.”